Role of fecal calprotectin as biomarker of gastrointestinal GVHD after allogeneic stem cell transplantation

Blood

Volumn 120, Issue 22, 2012, Pages 4443-4444

  Chiusolo, Patrizia ^a   Metafuni, Elisabetta ^a   Giammarco, Sabrina ^a   Bellesi, Silvia ^a   Piccirillo, Nicola ^a   Fanali, Chiara ^a   Castagnola, Massimo ^a   Zuppi, Cecilia ^a   De Michele, Teresa ^a   Leone, Giuseppe ^a   Sica, Simona ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CALGRANULIN; FECAL CALPROTECTIN; UNCLASSIFIED DRUG;

ACUTE GRAFT VERSUS HOST DISEASE; ALLOGENEIC STEM CELL TRANSPLANTATION; CHRONIC GRAFT VERSUS HOST DISEASE; COLITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FECES ANALYSIS; GASTROINTESTINAL DISEASE; GASTROINTESTINAL GRAFT VERSUS HOST REACTION; GRAFT VERSUS HOST REACTION; HUMAN; LETTER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

EID: 84869765865     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-08-447326     Document Type: Letter

References (4)

1. Rodriguez-Otero P, Porcher R., de Latour RP, et al. Fecal calprotectin and alpha-1 antitrypsin predict severity and response to corticosteroid in gastrointestinal graft-versus host disease. Blood. 2012;119(24):5909-5017.
2. Filipovich AH, Weisdorf D, Pavletic S, et al. National Institute of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant. 2005;11(12):945-956. (Pubitemid 41754712)
3. Przepiorka D, Weisdorf D, Martin P, et al. 1994 Consensus Conference on acute GVHD grading. Bone Marrow Transplant. 1995;15(6):825-828.
4. Bastos Oreiro MB, Castilla-Llorente C, de la Guia AL, et al. Fecal calprotectin in allogeneic stem cell transplantation for the diagnosis of acute intestinal graft versus host disease. Bone Marrow Transplant. 2012;47(9):1241-1242.